Stonepine Capital Management, LLC Enanta Pharmaceuticals Inc Transaction History
Stonepine Capital Management, LLC
- $124 Billion
- Q4 2024
A detailed history of Stonepine Capital Management, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 331,900 shares of ENTA stock, worth $2.67 Million. This represents 1.54% of its overall portfolio holdings.
Number of Shares
331,900Holding current value
$2.67 Million% of portfolio
1.54%Shares
11 transactions
Others Institutions Holding ENTA
# of Institutions
108Shares Held
19.7MCall Options Held
9.7KPut Options Held
12.4K-
Krensavage Asset Management, LLC New York, NY2.12MShares$17 Million7.2% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.11MShares$16.9 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$15.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$14.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.22MShares$9.81 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $166M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...